Dorsey & Whitney Trust CO LLC Trims Stock Position in Procter & Gamble Company (The) $PG

Dorsey & Whitney Trust CO LLC trimmed its holdings in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 13.6% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 48,564 shares of the company’s stock after selling 7,639 shares during the period. Dorsey & Whitney Trust CO LLC’s holdings in Procter & Gamble were worth $7,737,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Kingstone Capital Partners Texas LLC lifted its position in shares of Procter & Gamble by 655,209.0% in the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after acquiring an additional 76,017,350 shares in the last quarter. Nuveen LLC acquired a new position in Procter & Gamble in the 1st quarter valued at about $1,954,941,000. Price T Rowe Associates Inc. MD lifted its holdings in Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after purchasing an additional 2,466,308 shares in the last quarter. Invesco Ltd. boosted its stake in shares of Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock worth $2,299,580,000 after purchasing an additional 2,228,151 shares during the last quarter. Finally, Valeo Financial Advisors LLC grew its holdings in shares of Procter & Gamble by 1,875.5% during the second quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock worth $280,946,000 after buying an additional 1,674,139 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Price Performance

Procter & Gamble stock opened at $147.71 on Monday. The firm has a fifty day moving average of $151.83 and a 200-day moving average of $156.53. Procter & Gamble Company has a 52-week low of $144.09 and a 52-week high of $180.43. The company has a quick ratio of 0.51, a current ratio of 0.71 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $345.16 billion, a P/E ratio of 21.56, a PEG ratio of 3.87 and a beta of 0.36.

Procter & Gamble (NYSE:PGGet Free Report) last posted its earnings results on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.09. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The business had revenue of $22.39 billion for the quarter, compared to analyst estimates of $22.23 billion. During the same quarter in the previous year, the business posted $1.93 EPS. The business’s quarterly revenue was up 3.0% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, analysts predict that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Friday, October 24th will be issued a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a dividend yield of 2.9%. The ex-dividend date is Friday, October 24th. Procter & Gamble’s dividend payout ratio (DPR) is presently 61.61%.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on PG. Morgan Stanley set a $175.00 target price on shares of Procter & Gamble in a research report on Monday, October 27th. Wells Fargo & Company decreased their price objective on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a report on Thursday, September 25th. Berenberg Bank lifted their price objective on Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a research report on Wednesday, September 17th. BNP Paribas Exane reduced their target price on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research report on Tuesday, September 23rd. Finally, UBS Group decreased their price target on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. Twelve analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $171.53.

View Our Latest Analysis on PG

Insider Activity

In other news, insider Marc S. Pritchard sold 9,849 shares of the business’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,548,952.23. Following the transaction, the insider directly owned 182,422 shares of the company’s stock, valued at approximately $28,689,507.94. The trade was a 5.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Andre Schulten sold 11,638 shares of the company’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the completion of the transaction, the chief financial officer owned 52,642 shares of the company’s stock, valued at $8,279,007.34. This trade represents a 18.11% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 150,489 shares of company stock worth $23,529,864 in the last ninety days. 0.20% of the stock is currently owned by company insiders.

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.